ClinicalTrials.Veeva

Menu

Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology (TechnOXY)

University Hospital Basel logo

University Hospital Basel

Status

Enrolling

Conditions

Sonic Augmentation Technology

Treatments

Other: sonic augmentation technology

Study type

Interventional

Funder types

Other

Identifiers

NCT07276152
2025-01817, kt25christcrain6

Details and patient eligibility

About

The investigator aim to investigate wheather music modified by sonic augmentation technology can produce increasing oxytocin levels with minimal to no side effects in a highly standardized setting

Enrollment

22 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Part 1:

Inclusion Criteria:

  • Adult healthy controls
  • No medication, except hormonal contraception

Exclusion Criteria:

  • Participation in a trial with investigational drugs within 30 days
  • Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months
  • Consumption of alcoholic beverages >15 drinks/week
  • Tobacco smoking >10 cigarettes/day
  • Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder)
  • Psychotic disorder in first-degree relatives
  • Pregnancy and breastfeeding

Part 2:

Inclusion Criteria:

  • Confirmed diagnosis of AVP-Deficiency
  • Age ≥ 18 years

Exclusion Criteria:

  • Participation in a trial with investigational drugs within 30 days
  • Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months
  • Consumption of alcoholic beverages >15 drinks/week
  • Tobacco smoking >10 cigarettes/day
  • Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder)
  • Psychotic disorder in first-degree relatives
  • Pregnancy and breastfeeding

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

22 participants in 3 patient groups

Sonic augmentation technology (SAT) - placebo music
Experimental group
Description:
Participants will listen to music enhanced with SAT in their first study visit. After a washout-phase of at least 20 hours they will come to a second study visit and they will listen to placebo music
Treatment:
Other: sonic augmentation technology
placebo music- sonic augmentation technology (SAT) music
Experimental group
Description:
Participants will listen to placebo in their first study visit. After a washout-phase of at least 20 hours they will come to a second study visit and they will listen to music enhanced with SAT
Treatment:
Other: sonic augmentation technology
Sonic augmentation technology (SAT) in patients
Experimental group
Description:
Patients have one study visit listening to SAT
Treatment:
Other: sonic augmentation technology

Trial contacts and locations

1

Loading...

Central trial contact

Mirjam Christ-Crain, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems